Fermentalg SA (EPA:ALGAE)

Market Cap	42.57M +33.4%
Revenue (ttm)	12.78M +59.1%
Net Income	-11.54M
EPS	-0.12
Shares Out	89.71M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	169,261
Average Volume	218,440
Open	0.4525
Previous Close	0.4490
Day's Range	0.4475 - 0.4790
52-Week Range	0.2600 - 0.7300
Beta	1.24
RSI	59.07
Earnings Date	Apr 2, 2026

About Fermentalg

Fermentalg SA provides biosolutions based on aquatic micro-organisms in Europe, North America, Asia, and internationally. It offers DHA ORIGINS, a plant-based DHA oil; KALVEA PLUS, a nutritious algal protein concentrate dedicated to aquafeed applications; Everzure, an extract of natural acid stable blue color; BLUE ORIGINS AOX, an antioxidant and anti-inflammatory activities; and biobased raw materials for industry from their CO2 emissions. The company was incorporated in 2009 and is headquartered in Libourne, France.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2009
• Employees: 63
• Stock Exchange: Euronext Paris
• Ticker Symbol: ALGAE

Financial Performance

In 2024, Fermentalg's revenue was 11.50 million, an increase of 183.39% compared to the previous year's 4.06 million. Losses were -12.88 million, -8.99% less than in 2023.